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Abstract The effects of protein kinase C (PKC) inhibitors on
the metallothionein (MT) gene expression induced by metals
were investigated. When PKC inhibitor (H7 or chelerythrine)
was administered to Cd resistant, MT gene-amplified Chinese
hamster ovary (CdR) cells, the induction of MT mRNA by Cd or
Zn was blocked. Treating the CdR cells with a PKA-specific
inhibitor, HA1004, did not cause an inhibition of metal-induced
MT gene transcription. The inhibitory effect was effectuated by
adding inhibitors within 40 min of exposing the cells to Cd.
Apparently, AP1 was not involved in this down-regulatory effect
of PKC inhibitor on MT gene expression since the inducibility of
MT promoter was blocked by H7 even in the absence of the AP1-
binding sequence. For Cd-treated cells, Cd accumulation in the
cell was similar with or without H7 treatment. However, H7
markedly reduced cellular Zn accumulation when the cells were
treated with Zn. Cycloheximide treatment increased the level of
MT mRNA. This elevation can also be blocked by treating the
cell with PKC inhibitor. Results in this study suggest that PKC
participates in the process of metal-induced MT gene expression.
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1. Introduction
Metallothioneins (MTs) are sulfur-rich, metal-binding pro-
teins that exist ubiquitously in organisms [1]. Four families of
MTs have been identi¢ed. MTI and MTII are inducible pro-
teins and implicated in metal detoxi¢cation [2,3]. MTIII is a
brain-speci¢c, non-inducible protein identi¢ed in Alzheimer’s
disease-related studies [4,5]. The unique biological function of
MTIII is its ability to inhibit neuronal growth. MTIV is a
family of MTs that is present in squamous epithelium cells.
Although it has been proposed that MTIV is involved in
maintaining Zn homeostasis [6], its exact function remains
unclear. MTIII and MTIV have been isolated from mamma-
lian tissues; whether these proteins can be found in other
species remains unknown.
The expression of MTI and MTII genes is regulated pri-
marily at the transcriptional level [7,8]. Several homologous
repeats, i.e. metal responsive elements (MREs), have been
identi¢ed in the 5P-£anking region of MT genes. They can
only be activated upon metal stimulation [9,10]. Binding of
a transcriptional factor (MTF-1) to this region is needed for
the basal and metal-induced activities of MT promoters in
mammalian cells [11,12]. MTF-1 contains a zinc ¢nger do-
main that is responsible for binding with MREs. MTF-1 is
only active when Zn ions are present in the zinc ¢nger do-
main. This protein also has an acidic, a proline-rich and a
serine/threonine-rich domain that are involved in transcription
activation [11,13]. It has been proposed that MTF-1 serves as
a metal sensor and modulates the activity of the MT promoter
in response to changes in cellular Zn ion concentration [14].
However, a recent study indicates that an inhibitor might be
present and bind with MTF-1 [15]. The inhibitor is dissociated
from MTF-1 after Zn binding.
For other inducers, di¡erent control mechanisms are in-
volved. Among them, protein kinase C (PKC) plays a prom-
inent role in the transcriptional regulation. For instance, heme
is a unique compound that can activate the transcription of
the MT genes [16]. The induction mechanism of heme-hemo-
pexin has been demonstrated to be associated with the action
of PKC [17]. In addition, a PKC activator, phorbol ester, is
also known to be an inducer of MT [18,19]. These ¢ndings
indicate that the signal transduction pathway of PKC is crit-
ical in the transcriptional regulation of MT genes for several
chemicals. In this work, we demonstrated that inactivation of
PKC markedly a¡ects the metal-induced MT gene expression.
2. Materials and methods
2.1. Cell culture
The CHO K1 and CdR cells were cultured as monolayers at 37‡C in
McCoy’s 5A medium supplemented with 10% fetal bovine serum,
0.22% sodium bicarbonate, 100 units/ml penicillin and 100 Wg/ml
streptomycin, in an atmosphere of 5% CO2. Before transfection, the
cells were cultured at a density of 5U105 cells/60 mm petri dish for
18 h.
2.2. Plasmid construction, DNA transfection and CAT assay
The 5P-£anking region of CHO MTII gene (3925 to +62 relative to
the CAP site; see accession number M61714) was blunt-end ligated
with a pCAT-Basic (Promega, Madison, WI) plasmid that had been
digested at the XbaI site and ¢lled in by Klenow enzyme. The re-
combinant DNA was digested with HindIII to yield pMTII-253
[20]. The plasmid pMTII-142 was obtained by digesting pMTII-253
with PstI and SalI, followed by a nested deletion with a ExoIII/mung
bean nuclease kit (Stratagene). Transfections of the plasmids were
conducted by the cationic liposome method. The liposomes were pre-
pared by the procedures of Rose et al. [21]. Five Wg of promoter-
chloramphenicol acetyltransferase (CAT) gene construct was cotrans-
fected with 5 Wg pSV-L-galactosidase plasmid as an internal control
into the cells in each experiment so that the transfection e⁄ciency
could be adjusted. Optimal transfection e⁄ciency was obtained
when 30 Wl of liposome was used. Sixteen h after transfection, the
medium was replaced by a fresh medium. The cells were harvested 24
h after medium replacement, and chemicals were added to the me-
dium 10 h before cell harvest. The cells were removed by a rubber
policeman and lysed by three successive cycles of freezing and thawing
in liquid nitrogen and a 37‡C water bath. Cell debris were removed by
centrifugation, and the L-galactosidase activity in the supernatant was
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determined. Cell extracts (30 Wl) were heated at 60‡C for 10 min, and
0.25 M Tris-HCl (pH 7.8) was added to make the ¢nal volume of
100 Wl. One Wl of [3H]acetyl CoA (0.25 WCi/Wl), 2 Wl of 125 mM
chloramphenicol and 147 Wl of H2O were then mixed with the sample,
followed by 3 ml of scintillation £uid (Econo£uor-2, Du Pont). Radio-
activity in the sample was determined at various times thereafter by
a liquid scintillation analyzer (Packard Instrument Comp., Model
1600 CA). Radioactivity at ¢ve di¡erent time intervals was plotted
against the reaction time. A linear line can be obtained after regres-
sion. The slope of the line was used to determine CAT concentration
using a standard curve generated with known amount of CAT.
2.3. RNA extraction and Northern blot analysis
Cells were washed twice with chilled PBS, and 1 ml of the same
bu¡er was added to the petri dish. Cells were then removed using a
rubber policeman and collected into 1.5 ml microcentrifuge tubes.
Following centrifugation at 2000 rpm for 5 min at 4‡C, cell pellets
were resuspended in 0.5 ml of NTE (100 mM NaCl, 10 mM Tris-Cl,
pH 7.5, 1 mM EDTA). After adding 25 Wl of Nonidet P-40 and
standing on ice for 10 min, the samples were spun at 12 000 rpm
for 5 min in an Eppendorf microcentrifuge. Supernatants were then
transferred to new tubes and 50 Wl of 10% SDS was added. The
supernatants were successively extracted with 0.6 ml of water satu-
rated phenol and a phenol/chloroform/isoamyl alcohol (25:24:1) sol-
ution. RNA in the supernatant was precipitated with 1 ml of ethanol
at 370‡C for 1 h. The RNA was pelleted by centrifugation at 12 000
rpm for 10 min, and resuspended in diethylpyrocarbonate-treated
water. Equal amount of RNA from each treatment was separated
by electrophoresis on a 1.2% formaldehyde agarose gel and trans-
ferred onto a nitrocellulose membrane. Hybridization was conducted
as described by Ausubel et al. [22] using Chinese hamster metallothio-
nein-II cDNA [23] as probe. The 18S rRNA was used as an internal
standard for normalization of the amount of RNA applied.
2.4. Others
Metal contents in the samples were determined as described [24].
N-(2-guanidinoethyl)-5-isoquinolinesulfonamide (HA1004), 1-(5-iso-
quinolinylsulfonyl)-2-methylpiperazine (H7), chelerythrine chloride
and other chemicals were purchased from Sigma (St. Louis, MO).
Modi¢ed and restriction enzymes were obtained from Promega (Mad-
ison, WI).
3. Results
3.1. E¡ect of PKC inhibitors on the expression of MT mRNA
To investigate whether PKC is involved in the regulation of
metal-induced MT gene transcription, PKC inhibitor (H7)
was applied to cadmium resistant CHO cells (CdR) 2 h before
administering Cd. Comparing with the parental CHO K1, the
CdR cells have higher tolerance to metal toxicity and their MT
genes have been ampli¢ed 60- to 100-fold [25]. As indicated in
Fig. 1A, Cd markedly induced the synthesis of MT mRNA.
The MT mRNA expression was signi¢cantly reduced upon
H7 administration. The MT mRNA level, as compared with
samples without inhibitor treatment, reduced to 30.2 þ 4.6%,
24.2 þ 7.4%, 20.1 þ 6.5% and 15.1 þ 4.9% (mean þ standard de-
viation of three samples) when 50, 100, 200 and 300 WM of H7
was employed, respectively. This inhibitory e¡ect is not cell-
type speci¢c since a similar result was obtained when rat thy-
roid cells (GH3) were treated with 50 WM of H7 (unpublished
result).
To further demonstrate that this inhibitory e¡ect is due
primarily to the inactivation of PKC, a more potent and se-
lective PKC inhibitor, chelerythrine, was used. This inhibitor
blocks PKC activity when present at the micromolar level,
whereas more than 100-fold higher concentration is needed
for exerting a similar e¡ect on other protein kinases [26]. As
Fig. 1B reveals, the induction of MT mRNA by metal was
inhibited by chelerythrine. The ratio of MT gene expression
after treating the cells with chelerythrine was 93.6 þ 14.2%,
82.6 þ 6.5%, 62.3 þ 11.4% and 18.8 þ 14.7% (mean þ standard
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Fig. 1. E¡ect of protein kinase inhibitors on the MT mRNA expression induced by metals. Various protein kinase inhibitors were administered
to the CdR cells 2 h before metal treatments. Cd (5 WM) or Zn (100 WM) was then given to the cells for an additional 10 h, and MT mRNAs
were analyzed by Northern hybridization. The cells were treated with an increasing amount of H7 (A), chelerythrine (B) or HA1004 (C) before
Cd induction. The dose of H7 used was 0, 50, 100, 150, 200, 300, 400 and 500 WM, as indicated by number 1 to 8, respectively. The dose of
chelerythrine used was 0, 5, 7.5, 10 and 15 WM, as indicated by number 1 to 5, respectively. The HA1004 used was 0, 25, 50, 100 and 200 WM,
as indicated by number 1 to 5, respectively. Control samples without adding Cd or protein kinase inhibitor are designated as C. The e¡ect of
H7 on MT mRNA expression induced by Zn is presented in panel D. The cells were treated with metal in the absence (lane 1 to 3) or presence
(lane 4 to 6) of 200 WM H7. Lane 1 and 4: no metal added; lane 2 and 5: Cd added; lane 3 and 6: Zn added. The 18S rRNA (18S) was used
as an internal standard for quantitation of RNA loading in each lane.
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deviation of three samples) of the control when 5, 7.5, 10 and
15 WM of chelerythrine was given, respectively. These ¢ndings
clearly suggest that PKC is involved in the process of Cd-
induced MT gene expression.
Since H7 is also a potent inhibitor of PKA [27], we further
treated the cells with a PKA-speci¢c inhibitor, HA1004, to
investigate the role of PKA in the MT induction. As Fig.
1C reveals, this chemical has no e¡ect on MT mRNA induc-
tion. This ¢nding indicates that PKA is not involved in the
MT gene expression induced by metal.
In addition to Cd, Zn is also a very e¡ective inducer of MT
genes. The cellular response to Zn was examined to determine
whether the e¡ect of PKC on MT induction is metal speci¢c.
Cells were treated with Zn and H7, and MT mRNA levels
were analyzed. As shown in Fig. 1D, MT mRNA could also
be induced by Zn, and H7 could similarly prevent this induc-
tion. The result demonstrates that PKC is also involved in the
induction of MT gene expression by another potent metal
inducer. We used H7 in the following studies due to the stabil-
ity of the chemical. Although 50 WM of H7 can produce sig-
ni¢cant inhibitory e¡ect, we used a higher concentration of
the inhibitor to ensure that the PKC response could be easily
identi¢ed.
A time course study was conducted on the e¡ect of the
PKC inhibitor on the MT gene expression. The H7 was given
to the cells before or after Cd stimulation. The cells were
harvested 2 h after Cd exposure, and MT mRNA was ana-
lyzed by Northern hybridization. As shown in Fig. 2, metal-
induced MT mRNA synthesis can be blocked by H7 at several
time intervals. Blockage of MT gene expression occurred not
only when the inhibitor was given before the induction by
metal, but also at 20 min after stimulation. However, the
inhibition became less e¡ective when H7 was given 40 min
after Cd induction. The relative MT gene expression (amount
of MT mRNA normalized to that of 18S rRNA) increased
gradually and became similar to that of cells treated with Cd
when H7 was provided 90 min after metal exposure.
3.2. AP1 is not involved in the action of PKC on metal
induction of MT
Signal transduction via PKC pathway can modulate the
expression or phosphorylation status of c-jun/c-fos, resulting
in an elevation of AP1 activity [28,29]. The AP1 then further
regulates the expression of several genes. Since AP1-binding
sites have been identi¢ed in the CHO MT promoter regions, it
has been speculated that AP1 might be involved in the regu-
lation of MT gene expression via PKC [20,30]. To clarify such
a conjecture, CHO MTII promoter with (pMTII-253) or with-
out (pMTII-142) the AP1-binding site was fused with a chlor-
amphenicol acetyltransferase (CAT) gene, and transfected into
CHO K1 cells. The CAT activities were then compared for the
metal-induced cells with or without H7 treatment. As shown
in Fig. 3, the CAT activities increased as the cells carrying
pMTII-253 and pMTII-142 promoters were challenged with
metal. However, the activities dropped to the basal level when
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Fig. 2. A time course study of the inhibitory e¡ect of H7 on the
Cd-induced MT gene expression. The cells were treated with 5 WM
Cd for 2 h and MT mRNA was analyzed by Northern hybridiza-
tion. H7 (200 WM) was added either at 60 min before (360), at the
same time (0) or 10, 20, 40, 60 or 90 min after Cd administration.
The 18S rRNA (18S) was used as an internal standard for RNA
quantitation. C: control without Cd and H7; Cd: cells treated with
Cd only.
Fig. 3. E¡ect of H7 on the MT promoter activity. CHO MTII pro-
moter with (pMTII-253, A) or without (pMTII-142, B) the AP1 rec-
ognition sequence was inserted in front of a CAT gene and trans-
fected into CHO K1 cells. Ten h before harvest, cells were subjected
to the indicated treatments. CAT activity was determined after cell
lysis. The concentrations of Cd, Zn and H7 used in this experiment
were 5, 100 and 200 WM, respectively. Each value represents a
mean þ standard deviation of three samples.
Table 1
E¡ect of PKC inhibitor on cellular metal accumulation
Treatment Zn (fmole/cell) Cd (fmole/cell)
Control 1.19 þ 0.03 ND
Cd 1.38 þ 0.18 0.37 þ 0.07
Zn 4.81 þ 0.55 ND
H7 1.27 þ 0.19 ND
Cd+H7 1.14 þ 0.13 0.41 þ 0.13
Zn+H7 1.86 þ 0.05 ND
CdR cells were treated with metal in the presence or absence of H7 for
10 h, and cytosolic metal content was measured by atomic absorption
spectrophotometry. The concentrations of Cd, Zn and H7 adminis-
tered to the cells were 5, 100 and 200 WM, respectively. Each value
represents a mean þ standard deviation of three samples. ND, not
detectable.
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H7 was administered regardless of the presence or absence of
the AP1-binding site in the promoter region. This result dem-
onstrates not only that PKC regulates MT gene expression at
the transcriptional level, but also that AP1 is not involved in
the PKC action on the induction of MT by metal.
3.3. E¡ect of PKC inhibitor on the accumulation of metals in
the cells
The inhibitory e¡ect of MT gene expression after H7 ad-
ministration could be due to the blocking of metal transport
systems when cells are treated with metal. To address this
issue, the accumulations of metals in the CHO CdR cells
were examined after metal and H7 treatments. Table 1 reveals
that H7 did not inhibit Cd accumulation. The zinc content
was also not signi¢cantly altered when cells were treated with
either Cd, H7 or both. However, in contrast to the Cd treat-
ment, Zn accumulation was dramatically reduced in cells
treated with H7 and Zn, as compared to cells treated with
Zn only. Approximately 3 femtomoles of Zn per cell were
lost upon H7 treatment.
3.4. Possible target for the PKC action in MT induction
A model has been proposed by Palmiter [15] in which
MTF-1 is usually bound with an inhibitor. Upon metal in-
duction, the inhibitor is released and the MTF-1 becomes
e¡ective [15]. Since the involvement of PKC in the MT gene
transcription has been demonstrated in this study, the ulti-
mate regulatory site for the PKC action might be at either
the putative inhibitor or the MTF-1. To address this issue,
cells were treated with cycloheximide. The synthesis of the
MTF-1 inhibitor is considered to be cycloheximide sensitive
[15,31]. As Fig. 4 indicates, MT mRNA in CdR cells was
elevated in the presence of cycloheximide. This ¢nding agrees
with the proposed mechanism that a labile factor is present in
the cells to modulate MT gene expression. The addition of
cycloheximide with Cd or Zn to the cells further stimulates the
synthesis of MT mRNA. However, H7 blocked the elevation
of MT mRNA in the cycloheximide-treated cells regardless of
the presence or absence of metal. Results in this study imply
that the ultimate target of PKC action is more likely MTF-1
rather than labile factor.
4. Discussion
As generally accepted, induction of MT gene expression in
mammalian cells is attributed to the interactions among Zn
ion, MTF-1 and MREs. When cells are exposed to metal (e.g.
Zn or Cd), the metal (i.e. Zn) either directly activates MTF-1,
or the metal (i.e. Cd) replaces Zn from cellular components
and allows the free Zn to activate the transcriptional factor,
MTF-1. The MTF-1 can then bind MREs and activate the
MT gene transcription [15]. In the work reported here, we
showed that PKC is also involved in the process of MT
gene induction by metals. The participation of PKC in MT
gene regulation has been demonstrated in the stimulation of
MT gene expression by several chemicals. For instance, TPA,
which is a PKC activator, is also an inducer of MT [18,19].
Calcium ionophore, which perturbs cytosolic Ca concentra-
tion and results in an activation of PKC, increases the level
of MT mRNA [32,33]. A recent investigation con¢rmed that
induction of MT genes by heme-hemopexin is modulated by
PKC [17]. However, metal induction of MT gene expression
via the regulation of PKC has not been reported. By using
PKC inhibitors, MT induction can be eliminated. This e¡ect is
further demonstrated to be regulated at the transcriptional
level (Fig. 3). This regulation is not due to the action of
AP1, since MT expression can be blocked by the PKC inhib-
itor in the absence of the AP1-binding site at the promoter
region (Fig. 3).
Smith et al. [34] reported that cadmium can evoke inositol
polyphosphate formation and calcium mobilization via a pu-
tative ‘Cd receptor’. Signal transduction by those secondary
messengers can result in the activation of PKC. The MT in-
duction by Cd is therefore speculated to be controlled by this
mechanism. However, an antagonist of the pathway and also
a potent MT inducer, Zn, can not exert its inducibility of MT
mRNA in the presence of H7. If a common mechanism is
shared in the induction of MT by Zn or Cd, the secondary
messengers evoked by Cd certainly do not play a role in the
activation of MT gene transcription for both metals. Either a
di¡erent common mechanism that is not mediated by ‘Cd
receptor’, or possibly two separate mechanisms may exist
for MT induction by Cd and Zn.
When metal accumulation was examined, the H7 treatment
did not a¡ect Cd concentration (Table 1). This ¢nding sug-
gests that a lack of MT mRNA induction is not due to the
blocking of Cd transport. However, Zn concentration was
signi¢cantly reduced with the co-treatment of H7 and Zn.
The results demonstrate that Cd and Zn do not share the
same route for transport since Cd content is similar for either
the presence or absence of H7. If the reduction of MT mRNA
by H7 is due to the blocking of Zn transport during Zn
stimulation, the roles of the PKC inhibitor on MT induction
pathway should be expected to be di¡erent for Cd and Zn.
Nevertheless, it can not be ruled out that, in addition to Zn
transport, the induction of MT by Zn is also related to the
PKC activity.
Although MTF-1 is recognized to be a Zn sensor to mod-
ulate the activity of MT promoter, another MT regulatory
mechanism has been proposed. Palmiter has indicated that
MTF-1 is usually bound with an inhibitor when cells are
not stimulated by metals [15]. Upon induction by metal, the
inhibitor can be released by Zn and consequently causes the
activation of the MTF-1. Therefore, whether the ultimate tar-
FEBS 19637 17-12-97
Fig. 4. E¡ect of protein synthesis inhibitor and protein kinase inhib-
itor on the expression of MT mRNA. CHO CdR cells were treated
with cycloheximide (64 WM), Cd (5 WM) or Zn (100 WM) in the
presence or absence of H7 (200 WM) for 10 h. H7 was added 2 h
before the metal or cycloheximide treatment. The level of MT
mRNAs was analyzed by Northern hybridization. C: control; Cyc:
cycloheximide.
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get of PKC is on the MTF-1 or the putative inhibitor merits
investigation. An increase in MT mRNA by cycloheximide
treatment (Fig. 4) indicates that reduction in the synthesis
of a labile factor (inhibitor) in CdR cells allows active MTF-
1 to bind MREs and stimulates the expression of MT genes. If
the target of PKC is on the labile factor, H7 should not
change the MT mRNA level in the cycloheximide-treated cells
because the labile factor is absent. However, a decrease in MT
mRNA synthesis after administration of both H7 and cyclo-
heximide was observed (Fig. 4). This result implies that the
ultimate action of PKC is more likely on the MTF-1 but not
on the inhibitor.
Although our results do not directly demonstrate that phos-
phorylation occurs at the MTF-1, there is evidence that may
support this possibility. For example, a recent study using
mobility shift assays indicates that nuclear extracts prepared
from Zn-treated cells have higher MTF-1-binding activities
than those from uninduced cells [14]. This situation remains
the same when saturating amounts of Zn ions were added to
the in vitro binding reaction. Modi¢cation (e.g. phosphoryla-
tion) of the MTF-1 to modulate the transcriptional compe-
tence is one of the conceivable explanations [35]. When exam-
ining the MTF-1 amino acid sequence, several consensus PKC
phosphorylation sites [36] at the Zn ¢nger domain can be
identi¢ed [11,12]. In addition, a serine/threonine-rich domain
at the C-terminal of MTF-1 is also a region where phospho-
rylation can occur. Therefore, activation of MTF-1 by phos-
phorylation via a PKC-dependent pathway is possible in the
process of metal-induced MT gene expression.
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